Journal article : Comment

In patients with type 2 diabetes and CKD, finerenone improved CV and kidney outcomes

Abstract:: Agarwal R, Filippatos G, Pitt B, et al. Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis. Eur Heart J. 2022;43:474-84. ttps://pubmed.ncbi.nlm.nih.gov/35023547

Publication status:: Published

Peer review status:: Not peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Mayne, K. J., & Herrington, W. G. (2022). In patients with type 2 diabetes and CKD, finerenone improved CV and kidney outcomes. Annals of Internal Medicine, 175(5), JC54.

MLA Style

Mayne, K. J., and W. G. Herrington. “In Patients with Type 2 Diabetes and CKD, Finerenone Improved CV and Kidney Outcomes.” Annals of Internal Medicine, vol. 175, no. 5, American College of Physicians, 2022, p. JC54.

Chicago Style

Mayne, KJ, and WG Herrington. 2022. “In Patients with Type 2 Diabetes and CKD, Finerenone Improved CV and Kidney Outcomes.” Annals of Internal Medicine 175 (5): JC54.
Share
Print

Access Document

Files:: Mayne_and_Herrington_2022_In_patients_with.pdf

(Preview, Accepted manuscript, pdf, 98.5KB, Terms of use)

Publisher copy:: 10.7326/j22-0029

Authors

+ Mayne, KJ More by this author

Institution:: University of Oxford
Division:: MSD
Department:: Nuffield Department of Population Health
Role:: Author
ORCID:: 0000-0002-5695-0270

+ Herrington, WG More by this author

Institution:: University of Oxford
Division:: MSD
Department:: Nuffield Department of Population Health
Sub department:: Clinical Trial Service Unit
Role:: Author
ORCID:: 0000-0003-1172-8243

Publisher:: American College of Physicians
Journal:: Annals of Internal Medicine More from this journal
Volume:: 175
Issue:: 5
Pages:: JC54
Publication date:: 2022-05-03
DOI:: 10.7326/j22-0029
EISSN:: 1539-3704
ISSN:: 0003-4819
Pmid:: 35500259

Language:: English
Keywords:: FFR

kidney

diabetes mellitus, type 2

humans

naphthyridines

renal insufficiency, chronic
Subtype:: Comment
Pubs id:: 1262995
Local pid:: pubs:1262995
Deposit date:: 2022-10-20

Terms of use

Copyright holder:: American College of Physicians
Copyright date:: 2022
Rights statement:: © 2022 American College of Physicians
Notes:: This is the accepted manuscript version of the article. The final version is available from American College of Physicians at https://doi.org/10.7326/j22-0029

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP